Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Coagulation Disorder Neonatal”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT01687608
What this trial is testing

Open-Label Single Ascending Dose of Adeno-associated Virus Serotype 8 Factor IX Gene Therapy in Adults With Hemophilia B

Who this might be right for
Hemophilia B
Baxalta now part of Shire 30
Large-scale testing (Phase 3)Study completedNCT00885742
What this trial is testing

Factor XIII Concentrate in Subjects With Congenital Factor XIII Deficiency

Who this might be right for
Factor XIII Deficiency
CSL Behring 41
Not applicableStudy completedNCT02319070
What this trial is testing

2-cohort Study of Adult Patients With Severe Hemophilia A in Greece

Who this might be right for
Hemophilia A
Bayer 72
Large-scale testing (Phase 3)WithdrawnNCT06297486
What this trial is testing

Study of a Gene Therapy Treatment for Hemophilia A

Who this might be right for
Hemophilia A
Spark Therapeutics, Inc.
Early research (Phase 1)Study completedNCT01228669
What this trial is testing

Safety of NNC 0172-0000-2021 in Healthy Male Subjects and Subjects With Haemophilia A or B

Who this might be right for
Congenital Bleeding DisorderHaemophilia AHaemophilia B+1 more
Novo Nordisk A/S 52
Large-scale testing (Phase 3)Ended earlyNCT01405742
What this trial is testing

Hemophilia Adult Prophylaxis Study: Factor VIII in Severe Hemophilia A

Who this might be right for
Severe Hemophilia A
University of Pittsburgh 4
Testing effectiveness (Phase 2)Study completedNCT00496262
What this trial is testing

Human Fibrinogen - Pharmacokinetics

Who this might be right for
Fibrinogen Deficiency
CSL Behring 15
Not applicableEnded earlyNCT02569359
What this trial is testing

Efficacy and Safety of Shea Nut Oil in Hemophilic Arthropathy

Who this might be right for
HemophiliaHemophilic Arthropathy
Tri-Service General Hospital (TSGH) 6
Large-scale testing (Phase 3)Study completedNCT02250573
What this trial is testing

An Open-study to Investigate the Safety and Efficacy of Replenine®-VF in Haemophilia B Subjects Undergoing Surgery

Who this might be right for
Haemophilia B
Bio Products Laboratory
Early research (Phase 1)UnknownNCT02888223
What this trial is testing

Pharmacokinetic Study of SCT800 in Previously Treated Patients With Hemophilia A

Who this might be right for
Hemophilia A
Sinocelltech Ltd. 16
Not applicableLooking for participantsNCT04728841
What this trial is testing

Gene Therapy for Chinese Hemophilia A

Who this might be right for
Hemophilia AGene Therapy
Institute of Hematology & Blood Diseases Hospital, China 12
Testing effectiveness (Phase 2)Study completedNCT00489203
What this trial is testing

Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Hematopoietic/Lymphoid CancerAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in Remission+133 more
Fred Hutchinson Cancer Center 140
Large-scale testing (Phase 3)UnknownNCT05487976
What this trial is testing

Clinical Study of Recombinant Human Activated Coagulation Factor VII for Injection in Patients With Hemophilia With Inhibitor

Who this might be right for
Hemophilia AHemophilia B
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 50
Large-scale testing (Phase 3)Study completedNCT02740335
What this trial is testing

Study of Octaplex, a Four-factor Prothrombin Complex Concentrate (4F-PCC) and Beriplex® P/N (Kcentra) for the Reversal of Vitamin K Antagonist (VKA) Induced Anticoagulation in Patients Needing Urgent Surgery With Significant Bleeding Risk.

Who this might be right for
Significant Bleeding Risk
Octapharma 208
Large-scale testing (Phase 3)Study completedNCT04158648
What this trial is testing

Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of Emicizumab in Participants With Mild or Moderate Hemophilia A Without FVIII Inhibitors

Who this might be right for
Mild Hereditary Factor VIII Deficiency Disease Without InhibitorModerate Hereditary Factor VIII Deficiency Disease Without InhibitorHemophilia A
Hoffmann-La Roche 73
Testing effectiveness (Phase 2)Ended earlyNCT04434001
What this trial is testing

ZEPLAST- PED: ZEro_PLASma Trial in Small Infants Undergoing Cardiac Surgery

Who this might be right for
BleedingCardiac DefectSurgery--Complications+4 more
IRCCS Policlinico S. Donato 40
Not applicableUnknownNCT02197611
What this trial is testing

Development of a Specific Measure for Assessing Adherence in Adult Patients With Hemophilia.

Who this might be right for
Haemophilia
Universidad de Murcia 100
Testing effectiveness (Phase 2)UnknownNCT05441553
What this trial is testing

Evaluate the Safety and Efficacy of VGB-R04 in Adult Hemophilia B Patients

Who this might be right for
Hemophilia B
Shanghai Vitalgen BioPharma Co., Ltd. 26
Not applicableStudy completedNCT03157154
What this trial is testing

Bleeding Risk Evaluation in Haemophilia Patients Under Antiplatelet Therapies

Who this might be right for
Hemophilia
Nantes University Hospital 259
Not applicableUnknownNCT05523128
What this trial is testing

The Efficacy and Safety of ZS802 in Chinese Hemophilia A Patients.

Who this might be right for
Hemophilia A
Institute of Hematology & Blood Diseases Hospital, China 6
Next Page